galanthamine [extracellular region]

Stable Identifier
R-ALL-9635055
Type
ChemicalDrug
Compartment
Locations in the PathwayBrowser
for Species:
Literature References
PubMed ID Title Journal Year
11669505 Modulation of nicotinic receptor activity in the central nervous system: a novel approach to the treatment of Alzheimer disease

Santos, MD, Albuquerque, EX, Maelicke, A, Pereira, EF, Alkondon, M

Alzheimer Dis Assoc Disord 2001
12177686 Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease

Lilienfeld, S

CNS Drug Rev 2002
28678552 Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation

Mohammad, D, Chan, P, Bradley, J, Herrmann, N, Lanctôt, K

Expert Opin Drug Saf 2017
External Reference Information
Participates
Disease
Name Identifier Synonyms
Alzheimer's disease DOID:10652 AD, Alzheimers dementia, Alzheimer disease
Cross References
ChEBI
PharmacoDB
Cite Us!